FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2592759196> ?p ?o ?g. }

• W2592759196 endingPage "1222" @default.
• W2592759196 startingPage "1211" @default.
• W2592759196 abstract "Purpose To provide new information on adverse health outcomes (AHOs) in testicular cancer survivors (TCSs) after four cycles of etoposide and cisplatin (EPX4) or three or four cycles of bleomycin, etoposide, cisplatin (BEPX3/BEPX4). Methods Nine hundred fifty-two TCSs > 1 year postchemotherapy underwent physical examination and completed a questionnaire. Multinomial logistic regression estimated AHOs odds ratios (ORs) in relation to age, cumulative cisplatin and/or bleomycin dose, time since chemotherapy, sociodemographic factors, and health behaviors. Results Median age at evaluation was 37 years; median time since chemotherapy was 4.3 years. Chemotherapy consisted largely of BEPX3 (38.2%), EPX4 (30.9%), and BEPX4 (17.9%). None, one to two, three to four, or five or more AHOs were reported by 20.4%, 42.0%, 25.1%, and 12.5% of TCSs, respectively. Median number after EPX4 or BEPX3 was two (range, zero to nine and zero to 11, respectively; P > .05) and two (range, zero to 10) after BEPX4. When comparing individual AHOs for EPX4 versus BEPX3, Raynaud phenomenon (11.6% v 21.4%; P < .01), peripheral neuropathy (29.2% v 21.4%; P = .02), and obesity (25.5% v 33.0%; P = .04) differed. Larger cumulative bleomycin doses (OR, 1.44 per 90,000 IU) were significantly associated with five or more AHOs. Increasing age was a significant risk factor for one to two, three to four, or five or more AHOs versus zero AHOs (OR, 1.22, 1.50, and 1.87 per 5 years, respectively; P < .01); vigorous physical activity was protective (OR, 0.62, 0.51, and 0.41, respectively; P < .05). Significant risk factors for three to four and five or more AHOs included current (OR, 3.05 and 3.73) or former (OR, 1.61 and 1.76) smoking ( P < .05). Self-reported health was excellent/very good in 59.9% of TCSs but decreased as AHOs increased ( P < .001). Conclusion Numbers of AHOs after EPX4 or BEPX3 appear similar, with median follow-up of 4.3 years. A healthy lifestyle was associated with reduced number of AHOs." @default.
• W2592759196 created "2017-03-16" @default.
• W2592759196 creator A5002897454 @default.
• W2592759196 creator A5006940742 @default.
• W2592759196 creator A5016334652 @default.
• W2592759196 creator A5018335096 @default.
• W2592759196 creator A5018531384 @default.
• W2592759196 creator A5019116118 @default.
• W2592759196 creator A5026425735 @default.
• W2592759196 creator A5032809011 @default.
• W2592759196 creator A5035439869 @default.
• W2592759196 creator A5039202189 @default.
• W2592759196 creator A5039541486 @default.
• W2592759196 creator A5048660181 @default.
• W2592759196 creator A5062805582 @default.
• W2592759196 creator A5074254953 @default.
• W2592759196 creator A5080410100 @default.
• W2592759196 creator A5081688624 @default.
• W2592759196 creator A5087150696 @default.
• W2592759196 creator A5090040622 @default.
• W2592759196 date "2017-04-10" @default.
• W2592759196 modified "2023-09-25" @default.
• W2592759196 title "Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy" @default.
• W2592759196 cites W1150091873 @default.
• W2592759196 cites W1941234749 @default.
• W2592759196 cites W1952048380 @default.
• W2592759196 cites W1978515323 @default.
• W2592759196 cites W1998268494 @default.
• W2592759196 cites W2015403569 @default.
• W2592759196 cites W2015758016 @default.
• W2592759196 cites W2018968507 @default.
• W2592759196 cites W2020703194 @default.
• W2592759196 cites W2030248412 @default.
• W2592759196 cites W2031298612 @default.
• W2592759196 cites W2033228777 @default.
• W2592759196 cites W2036559481 @default.
• W2592759196 cites W2052592452 @default.
• W2592759196 cites W2057260087 @default.
• W2592759196 cites W2057783828 @default.
• W2592759196 cites W2059998155 @default.
• W2592759196 cites W2060372099 @default.
• W2592759196 cites W2071957083 @default.
• W2592759196 cites W2073076319 @default.
• W2592759196 cites W2074276081 @default.
• W2592759196 cites W2098064059 @default.
• W2592759196 cites W2101807916 @default.
• W2592759196 cites W2103886697 @default.
• W2592759196 cites W2105359710 @default.
• W2592759196 cites W2106193652 @default.
• W2592759196 cites W2106614331 @default.
• W2592759196 cites W2108539626 @default.
• W2592759196 cites W2109175854 @default.
• W2592759196 cites W2112652525 @default.
• W2592759196 cites W2113525441 @default.
• W2592759196 cites W2116169991 @default.
• W2592759196 cites W2136361773 @default.
• W2592759196 cites W2138433741 @default.
• W2592759196 cites W2140651954 @default.
• W2592759196 cites W2150719401 @default.
• W2592759196 cites W2150879111 @default.
• W2592759196 cites W2153743573 @default.
• W2592759196 cites W2158982839 @default.
• W2592759196 cites W2161993385 @default.
• W2592759196 cites W2162699291 @default.
• W2592759196 cites W2163826522 @default.
• W2592759196 cites W2165603392 @default.
• W2592759196 cites W2170186442 @default.
• W2592759196 cites W2172027353 @default.
• W2592759196 cites W2172255378 @default.
• W2592759196 cites W2204426862 @default.
• W2592759196 cites W2313420578 @default.
• W2592759196 cites W2331816360 @default.
• W2592759196 cites W2332889876 @default.
• W2592759196 cites W2438335613 @default.
• W2592759196 cites W2461141271 @default.
• W2592759196 cites W2466806233 @default.
• W2592759196 cites W2607031541 @default.
• W2592759196 cites W2689750974 @default.
• W2592759196 cites W2734681090 @default.
• W2592759196 cites W2915478882 @default.
• W2592759196 cites W4238251256 @default.
• W2592759196 cites W44254208 @default.
• W2592759196 doi "https://doi.org/10.1200/jco.2016.70.3108" @default.
• W2592759196 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5455601" @default.
• W2592759196 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28240972" @default.
• W2592759196 hasPublicationYear "2017" @default.
• W2592759196 type Work @default.
• W2592759196 sameAs 2592759196 @default.
• W2592759196 citedByCount "78" @default.
• W2592759196 countsByYear W25927591962017 @default.
• W2592759196 countsByYear W25927591962018 @default.
• W2592759196 countsByYear W25927591962019 @default.
• W2592759196 countsByYear W25927591962020 @default.
• W2592759196 countsByYear W25927591962021 @default.
• W2592759196 countsByYear W25927591962022 @default.
• W2592759196 countsByYear W25927591962023 @default.
• W2592759196 crossrefType "journal-article" @default.
• W2592759196 hasAuthorship W2592759196A5002897454 @default.

• next